Cara Therapeutics | CARA - Ação





Ação Alterar Data
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Assertio Holdings USD 24.76M 8.12M 2025-09
Cara Therapeutics USD 900K 0 2025-03
Chugai Pharma JPY 276.85B 30.52B 2025-12
Cipla INR 61.6B 5.18B 2025-09
Clal Biotechnology ILS 4.44M 0 2021-03
CSL USD 6.47B 327M 2025-06
Grifols EUR 3.56B 63.19M 2024-12
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
J&J USD 14.58B 392M 2026-03
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Pacira USD 150.37M 2.49M 2026-03
Pfizer USD 10.67B 13M 2026-03
RedHill Biopharma USD 3.17M 482K 2025-06
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03
Vanda Pharmaceuticals USD 1.85M 190K 2025-12